|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/55 | (2006.01) |
| C07D 471/16 | (2006.01) |
| (11) | Number of the document | 2262505 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09718951.8 |
| Date of filing the European patent application | 2009-03-12 | |
| (97) | Date of publication of the European application | 2010-12-22 |
| (45) | Date of publication and mention of the grant of the patent | 2014-09-10 |
| (46) | Date of publication of the claims translation | 2015-02-27 |
| (86) | Number | PCT/US2009/001608 |
| Date | 2009-03-12 |
| (87) | Number | WO 2009/114181 |
| Date | 2009-09-17 |
| (30) | Number | Date | Country code |
| 36069 P | 2008-03-12 | US |
| (72) |
WENNOGLE, Lawrence, P., US
TOMESCH, John, US
|
| (73) |
Intra-Cellular Therapies, Inc.,
3960 Broadway, New York, NY 10032,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Pakeistu heterociklu kondensuotų gama-karbolidų solidinės formos |
| SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SOLID |
| Payment date | Validity (years) | Amount | |
| 2026-02-13 | 18 | 347.00 EUR |
| 2027-03-12 |